Retraction of

• Transactivation of the CCL5/RANTES gene by Epstein-Barr virus latent membrane protein 1.

  Uchihara JN, Krensky AM, Matsuda T, Kawakami H, Okudaira T, Masuda M, Ohta T, Takasu N, Mori N. Uchihara JN, et al. Int J Cancer. 2005 May 1;114(5):747-55. doi: 10.1002/ijc.20784. Int J Cancer. 2005. Retraction in: Int J Cancer. 2011 Dec 1;129(11):2762-3. doi: 10.1002/ijc.26387. PMID: 15609310 Retracted.
• Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells.

  Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Ohshiro K, Mori N. Tomita M, et al. Int J Cancer. 2006 Feb 1;118(3):765-72. doi: 10.1002/ijc.21389. Int J Cancer. 2006. Retraction in: Int J Cancer. 2011 Dec 1;129(11):2762-3. doi: 10.1002/ijc.26387. PMID: 16106398 Retracted.
• Transactivation of the ICAM-1 gene by CD30 in Hodgkin's lymphoma.

  Uchihara JN, Matsuda T, Okudaira T, Ishikawa C, Masuda M, Horie R, Watanabe T, Ohta T, Takasu N, Mori N. Uchihara JN, et al. Int J Cancer. 2006 Mar 1;118(5):1098-107. doi: 10.1002/ijc.21427. Int J Cancer. 2006. Retraction in: Int J Cancer. 2011 Dec 1;129(11):2762-3. doi: 10.1002/ijc.26387. PMID: 16152613 Retracted.
• Inhibition of heat shock protein-90 modulates multiple functions required for survival of human T-cell leukemia virus type I-infected T-cell lines and adult T-cell leukemia cells.

  Kawakami H, Tomita M, Okudaira T, Ishikawa C, Matsuda T, Tanaka Y, Nakazato T, Taira N, Ohshiro K, Mori N. Kawakami H, et al. Int J Cancer. 2007 Apr 15;120(8):1811-20. doi: 10.1002/ijc.22403. Int J Cancer. 2007. Retraction in: Int J Cancer. 2011 Dec 1;129(11):2762-3. doi: 10.1002/ijc.26387. PMID: 17230513 Retracted.
• A modified version of galectin-9 suppresses cell growth and induces apoptosis of human T-cell leukemia virus type I-infected T-cell lines.

  Okudaira T, Hirashima M, Ishikawa C, Makishi S, Tomita M, Matsuda T, Kawakami H, Taira N, Ohshiro K, Masuda M, Takasu N, Mori N. Okudaira T, et al. Int J Cancer. 2007 May 15;120(10):2251-61. doi: 10.1002/ijc.22534. Int J Cancer. 2007. Retraction in: Int J Cancer. 2011 Dec 1;129(11):2762-3. doi: 10.1002/ijc.26387. PMID: 17278100 Retracted.
• Overexpression of Aurora A by loss of CHFR gene expression increases the growth and survival of HTLV-1-infected T cells through enhanced NF-kappaB activity.

  Tomita M, Toyota M, Ishikawa C, Nakazato T, Okudaira T, Matsuda T, Uchihara JN, Taira N, Ohshiro K, Senba M, Tanaka Y, Ohshima K, Saya H, Tokino T, Mori N. Tomita M, et al. Int J Cancer. 2009 Jun 1;124(11):2607-15. doi: 10.1002/ijc.24257. Int J Cancer. 2009. Retraction in: Int J Cancer. 2011 Dec 1;129(11):2762-3. doi: 10.1002/ijc.26387. PMID: 19230025 Retracted.
• Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV-1-infected T lymphocytes in vitro.

  Tomita M, Tanaka Y, Mori N. Tomita M, et al. Int J Cancer. 2010 Oct 1;127(7):1584-94. doi: 10.1002/ijc.25178. Int J Cancer. 2010. Retraction in: Int J Cancer. 2011 Dec 1;129(11):2762-3. doi: 10.1002/ijc.26387. PMID: 20091867 Retracted.